LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 154

Search options

  1. Article ; Online: Post-COVID-19 syndrome in everyday clinical practice: interdisciplinary expert position statement endorsed by the Polish Society of Civilization Diseases.

    Tomasiewicz, Krzysztof / Woron, Jaroslaw / Kobayashi, Adam / Krasinski, Zbigniew / Rydzewska, Grażyna / Szymanski, Filip M

    Polish archives of internal medicine

    2024  

    Abstract: Post-COVID-19 syndrome, also known as long-COVID-19 syndrome, is a complex set of symptoms that persist for weeks or months after recovery from the acute phase of COVID-19. These symptoms can affect various body systems, including the respiratory, ... ...

    Abstract Post-COVID-19 syndrome, also known as long-COVID-19 syndrome, is a complex set of symptoms that persist for weeks or months after recovery from the acute phase of COVID-19. These symptoms can affect various body systems, including the respiratory, nervous, cardiovascular, and digestive systems. The most common complaints are fatigue, shortness of breath, joint pain, taste and smell disorders, as well as problems with memory and concentration. The pathogenesis of the post-COVID-19 syndrome is complicated and not fully understood, but it is likely related to an overactive immune system, disturbances in the intestinal microbiome, and cell and tissue damage caused by the virus. Incorporating a multidisciplinary approach to treating and rehabilitating patients and further research into this syndrome's underlying mechanisms and therapy is crucial for understanding and effectively treating this complex and multi-faced condition.
    Language English
    Publishing date 2024-04-15
    Publishing country Poland
    Document type Journal Article
    ZDB-ID 123500-x
    ISSN 1897-9483 ; 0032-3772
    ISSN (online) 1897-9483
    ISSN 0032-3772
    DOI 10.20452/pamw.16728
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: The Role and Value of Professional Rapid Testing of Acute Respiratory Infections (ARIs) in Europe: A Special Focus on the Czech Republic, Poland, and Romania.

    Drevinek, Pavel / Flisiak, Robert / Nemes, Roxana / Nogales Crespo, Katya A / Tomasiewicz, Krzysztof

    Diagnostics (Basel, Switzerland)

    2024  Volume 14, Issue 6

    Abstract: This review aims to explore the role of professional diagnostic rapid testing of acute respiratory infections (ARIs), especially COVID-19 and influenza, ensuring proper disease management and treatment in Europe, and particularly in Czech Republic, ... ...

    Abstract This review aims to explore the role of professional diagnostic rapid testing of acute respiratory infections (ARIs), especially COVID-19 and influenza, ensuring proper disease management and treatment in Europe, and particularly in Czech Republic, Poland, and Romania. The paper was constructed based on a review of scientific evidence and national and international policies and recommendations, as well as a process of validation by four experts. The development of new testing technologies, treatment options, and increased awareness of the negative multidimensional impact of ARI profiles transformed differential diagnosis into a tangible and desirable reality. This review covers the following topics: (1) the multidimensional impact of ARIs, (2) ARI rapid diagnostic testing platforms and their value, (3) the policy landscape, (4) challenges and barriers to implementation, and (5) a set of recommendations illustrating a path forward. The findings indicate that rapid diagnostic testing, including at the point of care (POC), can have a positive impact on case management, antimicrobial and antibiotic stewardship, epidemiological surveillance, and decision making. Integrating this strategy will require the commitment of governments and the international and academic communities, especially as we identified room for improvement in the access and expansion of POC rapid testing in the focus countries and the inclusion of rapid testing in relevant policies.
    Language English
    Publishing date 2024-03-16
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2662336-5
    ISSN 2075-4418
    ISSN 2075-4418
    DOI 10.3390/diagnostics14060631
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: Recommendations for the diagnosis and treatment of Lyme borreliosis of the Polish Society of Epidemiologists and Infectious Disease Physicians.

    Moniuszko-Malinowska, Anna / Pancewicz, Sławomir / Czupryna, Piotr / Garlicki, Aleksander / Jaroszewicz, Jerzy / Marczyńska, Magdalena / Pawłowska, Małgorzata / Piekarska, Anna / Sikorska, Katarzyna / Simon, Krzysztof / Tomasiewicz, Krzysztof / Zajkowska, Joanna / Zarębska-Michaluk, Dorota / Flisiak, Robert

    Przeglad epidemiologiczny

    2024  Volume 77, Issue 3, Page(s) 261–278

    MeSH term(s) Humans ; Communicable Diseases ; Epidemiologists ; Lyme Disease/diagnosis ; Lyme Disease/drug therapy ; Physicians ; Poland
    Language English
    Publishing date 2024-02-03
    Publishing country Poland
    Document type Journal Article ; Practice Guideline
    ZDB-ID 421782-2
    ISSN 0033-2100
    ISSN 0033-2100
    DOI 10.32394/pe.77.25
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: Recommendations for the management of rickettsioses.

    Tomasiewicz, Krzysztof

    Przeglad epidemiologiczny

    2015  Volume 69, Issue 2, Page(s) 299–302, 411–4

    MeSH term(s) Anti-Bacterial Agents/therapeutic use ; Anti-Infective Agents/therapeutic use ; Antibodies, Bacterial/blood ; Disease Outbreaks/prevention & control ; Female ; Humans ; Immunoglobulin M/blood ; Male ; Poland ; Primary Prevention/methods ; Rickettsia Infections/diagnosis ; Rickettsia Infections/drug therapy ; Rickettsia Infections/prevention & control
    Chemical Substances Anti-Bacterial Agents ; Anti-Infective Agents ; Antibodies, Bacterial ; Immunoglobulin M
    Language Polish
    Publishing date 2015
    Publishing country Poland
    Document type Journal Article
    ZDB-ID 421782-2
    ISSN 0033-2100
    ISSN 0033-2100
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: Recommendations of the Polish Group of Experts for HCV for the treatment of hepatitis C in 2023.

    Tomasiewicz, Krzysztof / Flisiak, Robert / Jaroszewicz, Jerzy / Małkowski, Piotr / Pawłowska, Małgorzata / Piekarska, Anna / Simon, Krzysztof / Zarębska-Michaluk, Dorota

    Clinical and experimental hepatology

    2023  Volume 9, Issue 1, Page(s) 1–8

    Abstract: The recommendations define the principles of diagnosis and treatment of hepatitis C virus (HCV) infection according to the latest knowledge. The main goal of the treatment of HCV infection is to eliminate the virus from the body, which in turn leads to ... ...

    Abstract The recommendations define the principles of diagnosis and treatment of hepatitis C virus (HCV) infection according to the latest knowledge. The main goal of the treatment of HCV infection is to eliminate the virus from the body, which in turn leads to stopping the progression or causes the regression of previously formed changes in the liver. The current version of the guidelines prioritizes pangenotypic regimens and includes guidelines for special patient populations such as children, patients with cirrhosis, human immunodeficiency virus (HIV) and hepatitis B virus (HBV) infection, patients with renal failure, liver failure and lack of response to previous therapies as well as patients in the peri-transplant period.
    Language English
    Publishing date 2023-03-24
    Publishing country Poland
    Document type Journal Article ; Review
    ZDB-ID 2937940-4
    ISSN 2449-8238 ; 2392-1099
    ISSN (online) 2449-8238
    ISSN 2392-1099
    DOI 10.5114/ceh.2023.125957
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article: COVID-19 prophylaxis, diagnostics, and treatment in patients with rheumatic diseases. The Polish experts panel opinion.

    Kwiatkowska, Brygida / Krajewska-Włodarczyk, Magdalena / Batko, Bogdan / Maślińska, Maria / Stajszczyk, Marcin / Świerkot, Jerzy / Wiland, Piotr / Żuber, Zbigniew / Tomasiewicz, Krzysztof

    Reumatologia

    2024  Volume 62, Issue 1, Page(s) 4–17

    Abstract: As severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) evolves, infection management in vulnerable populations requires formalized guidance. Although low-virulence variants of SARS-CoV-2 remain predominant, they pose an increased risk of severe ... ...

    Abstract As severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) evolves, infection management in vulnerable populations requires formalized guidance. Although low-virulence variants of SARS-CoV-2 remain predominant, they pose an increased risk of severe illness in adults with rheumatic and musculoskeletal diseases (RMDs). Several disease-specific (chronic long-grade inflammation, concomitant immunosuppression) and individual (advanced age, multimorbidity, pregnancy, vaccination status) factors contribute to excess risk in RMD populations. Various post-COVID-19 manifestations are also increasingly reported and appear more commonly than in the general population. At a pathogenetic level, complex interplay involving innate and acquired immune dysregulation, viral persistence, and genetic predisposition shapes a unique susceptibility profile. Moreover, incident cases of SARS-CoV-2 infection as a trigger factor for the development of autoimmune conditions have been reported. Vaccination remains a key preventive strategy, and encouraging active education and awareness will be crucial for rheumatologists in the upcoming years. In patients with RMDs, COVID-19 vaccines' benefits outweigh the risks. Derivation of specialized diagnostic and therapeutic protocols within a comprehensive COVID-19 care plan represents an ideal scenario for healthcare system organization. Vigilance for symptoms of infection and rapid diagnosis are key for introducing antiviral treatment in patients with RMDs in a timely manner. This review provides updated guidance on optimal immunization, diagnosis, and antiviral treatment strategies.
    Language English
    Publishing date 2024-03-18
    Publishing country Poland
    Document type Journal Article
    ZDB-ID 604151-6
    ISSN 0034-6233
    ISSN 0034-6233
    DOI 10.5114/reum/183469
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: A rotablation-resistant lesion: rare and highly challenging to treat percutaneously.

    Rakotoarison, Oscar / Ściborski, Krzysztof / Zimoch, Wojciech / Tomasiewicz, Brunon / Reczuch, Krzysztof / Kübler, Piotr

    Kardiologia polska

    2021  Volume 79, Issue 2, Page(s) 209–210

    MeSH term(s) Angioplasty, Balloon, Coronary ; Atherectomy, Coronary ; Humans
    Language English
    Publishing date 2021-01-18
    Publishing country Poland
    Document type Journal Article
    ZDB-ID 411492-9
    ISSN 1897-4279 ; 0022-9032
    ISSN (online) 1897-4279
    ISSN 0022-9032
    DOI 10.33963/KP.15758
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Sexual Dysfunction and Quality of Life in Patients with Rheumatoid Arthritis.

    Tański, Wojciech / Dudek, Krzysztof / Tomasiewicz, Anna / Świątoniowska-Lonc, Natalia

    International journal of environmental research and public health

    2022  Volume 19, Issue 5

    Abstract: Background: Sexual health is a major component of human well-being. As repeatedly shown in research, satisfaction with sex life and sexual fulfillment correlate positively with quality of life (QoL) in most of its aspects. It is thus true that a reduced ... ...

    Abstract Background: Sexual health is a major component of human well-being. As repeatedly shown in research, satisfaction with sex life and sexual fulfillment correlate positively with quality of life (QoL) in most of its aspects. It is thus true that a reduced quality of one’s sex life and lack of sexual fulfillment can contribute to poorer QoL overall. The aim of this study is to describe an assessment of sexual dysfunction and factors affecting sexual dysfunctions of patients with rheumatoid arthritis (RA). Material and methods: 171 consecutive RA patients (mean age 48.3 ± 14.6) attending the rheumatology outpatient clinic. Standardized questionnaires used in the study were the sexological questionnaire, WHOQOL-BREF to assess QoL level, Disease Acceptance Scale, and VAS scale to assess pain intensity. Results: The mean duration of the disease in the study group was 13 ± 9 years, mean score of subjective assessment of mobility was 6.2 ± 1.6, and the mean score of the DAS-28 was 4.0 ± 1.9. The study group presented a mean level of disease acceptance (AIS 29.6 ± 11.6). The comparative analysis showed significant differences in reaching orgasm and declared sexual dysfunctions. These problems occurred more often in women than in men (34.2% vs. 18% and 43% vs. 40%, respectively). In univariate analysis, factors correlating positively with the frequency of declaring sexual dysfunction were subjective motor score less < 6 points, AIS < 36 points, WHOQOL-BREF < 59 points, disease activity ≥3.5 points, and VAS > 3. In multivariate logistic regression analysis, independent factors positively correlating with frequency of sexual dysfunction declaration were general QoL (β = 1.255; p = 0.035) and pain limiting social life (β = 1.564; p = 0.030). The absence of comorbidities correlated negatively and reduced the prevalence of sexual dysfunction (β = −1.030; p = 0.043). Patients with reduced QoL and patients with pain limiting social life had 3.5 and 4.8 times higher risk of sexual dysfunction than other patients, respectively. In contrast, those without comorbidities were 2.8 times more likely to be free of sexual dysfunction than those diagnosed with other chronic diseases besides RA. Conclusions: Sexual dysfunction is an emerging problem in both men and women with RA. The absence of comorbidities is an independent determinant of sexual dysfunction, whereas poor QoL and pain limiting social life are independent determinants that exacerbate sexual dysfunction in both genders.
    MeSH term(s) Adult ; Arthritis, Rheumatoid/complications ; Arthritis, Rheumatoid/epidemiology ; Female ; Humans ; Male ; Middle Aged ; Pain/epidemiology ; Quality of Life ; Sexual Dysfunction, Physiological/epidemiology ; Sexual Dysfunction, Physiological/etiology ; Surveys and Questionnaires
    Language English
    Publishing date 2022-03-06
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2175195-X
    ISSN 1660-4601 ; 1661-7827
    ISSN (online) 1660-4601
    ISSN 1661-7827
    DOI 10.3390/ijerph19053088
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Sexual Dysfunction and Quality of Life in Patients with Rheumatoid Arthritis

    Wojciech Tański / Krzysztof Dudek / Anna Tomasiewicz / Natalia Świątoniowska-Lonc

    International Journal of Environmental Research and Public Health, Vol 19, Iss 3088, p

    2022  Volume 3088

    Abstract: Background: Sexual health is a major component of human well-being. As repeatedly shown in research, satisfaction with sex life and sexual fulfillment correlate positively with quality of life (QoL) in most of its aspects. It is thus true that a reduced ... ...

    Abstract Background: Sexual health is a major component of human well-being. As repeatedly shown in research, satisfaction with sex life and sexual fulfillment correlate positively with quality of life (QoL) in most of its aspects. It is thus true that a reduced quality of one’s sex life and lack of sexual fulfillment can contribute to poorer QoL overall. The aim of this study is to describe an assessment of sexual dysfunction and factors affecting sexual dysfunctions of patients with rheumatoid arthritis (RA). Material and methods: 171 consecutive RA patients (mean age 48.3 ± 14.6) attending the rheumatology outpatient clinic. Standardized questionnaires used in the study were the sexological questionnaire, WHOQOL-BREF to assess QoL level, Disease Acceptance Scale, and VAS scale to assess pain intensity. Results: The mean duration of the disease in the study group was 13 ± 9 years, mean score of subjective assessment of mobility was 6.2 ± 1.6, and the mean score of the DAS-28 was 4.0 ± 1.9. The study group presented a mean level of disease acceptance (AIS 29.6 ± 11.6). The comparative analysis showed significant differences in reaching orgasm and declared sexual dysfunctions. These problems occurred more often in women than in men (34.2% vs. 18% and 43% vs. 40%, respectively). In univariate analysis, factors correlating positively with the frequency of declaring sexual dysfunction were subjective motor score less < 6 points, AIS < 36 points, WHOQOL-BREF < 59 points, disease activity ≥3.5 points, and VAS > 3. In multivariate logistic regression analysis, independent factors positively correlating with frequency of sexual dysfunction declaration were general QoL (β = 1.255; p = 0.035) and pain limiting social life (β = 1.564; p = 0.030). The absence of comorbidities correlated negatively and reduced the prevalence of sexual dysfunction (β = −1.030; p = 0.043). Patients with reduced QoL and patients with pain limiting social life had 3.5 and 4.8 times higher risk of sexual dysfunction than other patients, ...
    Keywords sexual dysfunctions ; quality of life ; rheumatoid arthritis ; Medicine ; R
    Subject code 360
    Language English
    Publishing date 2022-03-01T00:00:00Z
    Publisher MDPI AG
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  10. Article ; Online: Concentration of LDLR, degree of hepatic fibrosis and hepatic steatosis in patients with chronic hepatitis B infection treated with tenofovir disoproxil fumarate.

    Pokora-Rodak, Agnieszka / Krzowska-Firych, Joanna / Tomasiewicz, Krzysztof

    Annals of agricultural and environmental medicine : AAEM

    2020  Volume 28, Issue 3, Page(s) 458–462

    Abstract: Introduction: Epidemiological data indicate that one-third of the world's population have serological markers of hepatitis B virus infection. Hepatic steatosis is often observed in patients with chronic liver diseases. The exact mechanisms of hepatic ... ...

    Abstract Introduction: Epidemiological data indicate that one-third of the world's population have serological markers of hepatitis B virus infection. Hepatic steatosis is often observed in patients with chronic liver diseases. The exact mechanisms of hepatic steatosis progression and the efficacy of antiviral therapy in patients with CHB and hepatic steatosis are not yet fully understood.
    Objective: The aim of the study was to investigate the LDLR concentration and degree of hepatic fibrosis and hepatic steatosis in patients with chronic hepatitis B infection during tenofovir disoproxil fumarate therapy.
    Material and methods: The study group consisted of 54 patients with CHB. The LDLR concentration, assessment of the degree of hepatic fibrosis, hepatic steatosis, total cholesterol, low density lipoprotein, high density lipoprotein and triglyceride concentrations, were assessed at the beginning of therapy, 6 months later, and 12 months after commencement of therapy. The control group consisted of 18 healthy individuals.
    Results: The mean LDLR concentration in the studied groups was statistically significantly lower (p<0.05) than in the controls. The antiviral therapy based on TDF had no influence on the LDLR concentration and HBsAg level.
    Conclusions: The results indicate a statistically significant lower(p<0.05) concentration of LDLR in patients with chronic hepatitis B infection. Negative correlations between HBsAg level and LDLR concentration in patients with chronic HBV, at all stages of the study may indicate, that HBsAg protects hepatocytes from LDL accumulation.
    MeSH term(s) Adult ; Aged ; Antiviral Agents/administration & dosage ; Fatty Liver/blood ; Fatty Liver/etiology ; Fatty Liver/virology ; Female ; Hepatitis B Surface Antigens/blood ; Hepatitis B virus/genetics ; Hepatitis B virus/metabolism ; Hepatitis B, Chronic/blood ; Hepatitis B, Chronic/complications ; Hepatitis B, Chronic/drug therapy ; Hepatitis B, Chronic/virology ; Humans ; Lipoproteins, HDL/blood ; Liver Cirrhosis/blood ; Liver Cirrhosis/etiology ; Liver Cirrhosis/virology ; Male ; Middle Aged ; Receptors, LDL/blood ; Tenofovir/administration & dosage ; Triglycerides/blood
    Chemical Substances Antiviral Agents ; Hepatitis B Surface Antigens ; LDLR protein, human ; Lipoproteins, HDL ; Receptors, LDL ; Triglycerides ; Tenofovir (99YXE507IL)
    Language English
    Publishing date 2020-06-10
    Publishing country Poland
    Document type Journal Article
    ZDB-ID 1215115-4
    ISSN 1898-2263 ; 1232-1966
    ISSN (online) 1898-2263
    ISSN 1232-1966
    DOI 10.26444/aaem/122627
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top